Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 94 for “"HBV-DNA"”.
-
Comparison of Serum HBV DNA Levels between Lamivudine Induced HBeAg Seroconversion and Spontaneous Seroconversion
… B. The aim of this study was to compare serum HBV DNA levels at the time of HBeAg seroconversion between these two groups. METHODS: We retrospectively analyzed 37 patients with chronic hepatitis B. Among them, 14 were seroconverted during lamivudine therapy and 13 were not seroconverted during …
-
Pesquisa do HBV-DNA em doadores de sangue com diferentes perfis sorológicos para hepatite B
… na fase crônica podem conter quantidades de HBV-DNA muito baixas e não ser detectado por testes moleculares. Ainda existe um risco de transmissão que ocorre se o doador estiver na fase inicial da infecção, antes da detecção do HBsAg e que pode ser evitado pesquisando-se o HBV-DNA. Testes para …
-
MUTATION IN THE SURFACE AND CORE GENE OF HBV DNA IN HCC PATIENTS NEGATIVE FOR THE SURFACE ANTIGEN
… patients, three patients were found to harbour HBV DNA despite negative for the surface antigen by conventional diagnostic assays. All three patients were Chinese males approaching their seventh decade. The three patients were negative for HBsAg and HBeAg but positive for anti-HBc. Two of the …
-
Association of HBV DNA and ALT Level with YMDD motif Mutation Type in Lamivudine Resistance for Chronic Hepatitis B
… of lamivudine resistant hepatitis B virus(HBV), with point mutation in the YMDD motif of DNA polymerase gene, has been reported in chronic hepatitis B patients with lamivudine treatment. The aim of this study was to investigate the distribution patterns and clinical aspects of lamivudine …
-
Die Wirksamkeit der antiviralen Therapie bei chronischer Hepatitis-B-Infektion je nach ALT und HBV DNA: ein systematisches Review und Meta-analyse
… (NA) je nach Ausgangswert der Viruslast (HBV DNA) und Alanin-Aminotransferase (ALT) sind, insbesondere bei Patienten ohne Zirrhose und mit niedriger Viruslast oder normaler ALT. Zur Unterstützung der WHO-Leitlinien 2024 wurde eine systematische Übersichtsarbeit und Meta-Analyse …
-
Prävalenz okkulter Hepatitis B Infektionen bei chronischen Hämodialyse- und nierentransplantierten Patienten
… definiert als die Präsenz von Hepatitis B Virus (HBV) DNA im Serum und/ oder in Hepatozyten in HBsAg-negativen Patienten. Die Prävalenz und klinische Relevanz der OBI bei Hämodialyse Patienten und Nierentransplantierten sind bisher ungeklärt, deshalb wurden sie in dieser großen Querschnittsstudie …
-
Φυσική ιστορία και διαφορική διάγνωση της HBeAg αρνητικής χρόνιας HBV λοίμωξης με αρχικά φυσιολογικές τρανσαμινάσες
We evaluated the longitudinal changes of serum HBV DNA levels in two cohorts of untreated patients with HBeAg-negative chronic HBV infection. We studied 185 inactive HBV carriers and 165 chronic hepatitis B (CHB) patients classified according to their ALT activity within the first year of close …
-
Expression and Functional Analysis of Hepatitis B Virus DNA Polymerase
PART I: Expression of chimeric DNA polymerase of human and duck hepatitis B virus Hepatitis B Virus (HBV) DNA polymerase is a multifunctional protein with four domains, terminal protein (TP), spacer, reverse transcriptase (RT), and RNaseH. Since HBV DNA polymerase is very unstable and rapidly …
-
Ο ρόλος της περιγεννητικής ιαιμίας της μητέρας στη μετάδοση του ιού της ηπατίτιδας Β στο νεογνό και η πρόβλεψη αυτής μέσω της ηπατικής βιοχημείας
Introduction: The levels of maternal viremia (HBV–DNA) during the third trimester of pregnancy are the most important risk factor for perinatal transmission of hepatitis B virus (HBV) infection and for failure of the immunoprophylaxis applied. High levels of viremia are mainly observed in women …
-
Προσδιορισμός της ιαιμίας από τον ιό της ηπατίτιδας Β (HBV) με τη χρήση πραγματικού χρόνου PCR σε ασθενείς που βρίσκονται σε θεραπεία υποκατάστασης για χρόνια νεφρική ανεπάρκεια
Hepatitis B virus infection (HBV) is an important cause of liver disease in the end-stage renal failure patients (ESRF) treated by haemodialysis. Occult HBV infection is characterised by undetectable serum HBsAg but detectable HBV-DNA in serum or the liver. Occult HBV infection has been reported in …
-
Características subgenotípicas, filogenéticas e correlação entre os níveis séricos do antígeno de superfície do vírus da hepatite B e o HBV DNA (viremia). Recife, Brasil
… subgenotípica do vírus da hepatite B (HBV) e elaborar estudo evolutivo através da confecção da árvore filogenética. O segundo objetivou avaliar a correlação entre os níveis séricos do antígeno de superfície do vírus da hepatite B (HBsAg) e a quantificação do HBV DNA (viremia). No …
-
Initial Stages of Hepatitis B Virus Replication
PART 1 Intracellular Trafficking of HBV Core Particle in Various Stage of DNA Replication Inside of hepatitis B virus (HBV) core particle, pgRNA is reverse transcribed by HBV DNA polymerase into minus-strand DNA and pregenomic RNA (pgRNA) is degraded concomitantly by RNase H activity of DNA …
-
CARATTERIZZAZIONE DELL'INFEZIONE DA VIRUS DELL'EPATITE B (HBV) IN UNA COORTE DI SOGGETTI HIV-POSITIVI IN MALAWI
Background. This study aimed at evaluating both HBV and occult HBV infection prevalence in a cohort of HIV-positive women receiving HAART. Methods. This retrospective laboratory-based study was performed on 1,006 plasma samples collected from women (median age:31 years; range:15-70 years) referred …
-
Durability after discontinuation of nucleos(t)ide therapy in chronic HBeAg negative hepatitis patients
… at least three times undetectable level of HBV DNA leave 6months space in 45 patients. (25 with entecavir, 14 with lamivudine, 6 with adefovir.) All patients had followed up at least 1 year after stopping NUC therapy. Serum ALT, AST and HBV DNA levels were measured every 3 months. Clinical …
-
Clinical Course of Partial Virological Responders
… of ETV therapy, respectively (P=0.008). Low HBV DNA level at 12 months (P<0.001) and absence of a LAM treatment history (P =0.031) were significant associated factors for VR. In VR prediction at 36 months of ETV therapy in NUC- naïve patients, HBV DNA level <95 IU/ml at 12 months showed a …
-
Πρόωρος τοκετός και βάρος γέννησης νεογνών γυναικών με χρόνια λοίμωξη από τον ιό ηπατίτιδας Β
Aim: The effect of maternal chronic HBV infection on pregnancy outcome and especially on birth weight is debatable. There are no data regarding birth weight outcome and well known viral-disease activity parameters (maternal HBV-DNA levels / HBsAg quantification). The aim of the study was to …
-
Sequencing of serum hepatitis B virus (HBV) RNA as a novel method for the genome analysis of HBV
The genome of hepatitis B virus (HBV) can be assessed by sequence analysis of HBV DNA in serum. In most chronic HBV infected patients treated with potent nucleos(t)ide analogues (NAs) this approach however is limited by the fast decrease of serum HBV DNA during NA treatment. In contrast, HBV RNA …
-
Συχνότητα και σημασία της λανθάνουσας ιαιμίας από τον ιό της ηπατίτιδας Β σε ασθενείς με χρόνια ηπατίτιδα C
Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are considered to be the most common causes of liver disease worldwide. Both viruses are transmitted, mainly, parenterally and they share similar risk factors for transmission. As a consequence the combined HBV and HCV infection is …
Page 1 of 5